Drug Shortage Report for SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE

Last updated on 2019-06-28 History
Report ID 81730
Drug Identification Number 02470438
Brand name SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE
Common or Proper name Perindopril Erbu/Inda
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) PERINDOPRIL ERBUMINE INDAPAMIDE
Strength(s) 4MG 1.25MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30
ATC code C09BA
ATC description ACE INHIBITORS, COMBINATIONS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-03-25
Estimated end date 2019-05-20
Actual end date 2019-05-24
Shortage status Resolved
Updated date 2019-06-28
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-04-15 English Compare
v2 2019-04-15 French Compare
v3 2019-05-07 English Compare
v4 2019-05-07 French Compare
v5 2019-06-28 English Compare
v6 2019-06-28 English Compare
v7 2019-06-28 French Compare

Showing 1 to 7 of 7